Generation of recombinant hyperimmune globulins from diverse B-cell repertoires

[1]  Jeffrey R. Kugelman,et al.  Recent successes in therapeutics for Ebola virus disease: no time for complacency , 2020, The Lancet Infectious Diseases.

[2]  Wayne T. Nicholson,et al.  Deployment of convalescent plasma for the prevention and treatment of COVID-19. , 2020, The Journal of clinical investigation.

[3]  Jing Yuan,et al.  Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. , 2020, JAMA.

[4]  Philip L. Felgner,et al.  A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, medRxiv.

[5]  Robert C. Edgar,et al.  Massively parallel interrogation and mining of natively paired human TCRαβ repertoires , 2020, Nature Biotechnology.

[6]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[7]  H. Qiu,et al.  Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice , 2019, Scientific Reports.

[8]  M. Koopmans,et al.  The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis , 2019, PLoS pathogens.

[9]  Robert C. Edgar,et al.  Preferential Identification of Agonistic OX40 Antibodies by Using Cell Lysate to Pan Natively Paired, Humanized Mouse-Derived Yeast Surface Display Libraries , 2019, Antibodies.

[10]  James E. Crowe,et al.  High frequency of shared clonotypes in human B cell receptor repertoires , 2019, Nature.

[11]  A. Israni,et al.  OPTN/SRTR 2016 Annual Data Report: Kidney , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  M. Halloran,et al.  Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.

[13]  N. Jewell,et al.  Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure , 2017, The Journal of pediatrics.

[14]  Robert C. Edgar,et al.  Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics , 2017, mAbs.

[15]  W. Vach,et al.  Respiratory Infections and Antibiotic Usage in Common Variable Immunodeficiency , 2017, The Journal of Allergy and Clinical Immunology: In Practice.

[16]  Angus M. Sidore,et al.  Multiplexed gene synthesis in emulsions for exploring protein functional landscapes , 2017, Science.

[17]  J. Jorquera,et al.  Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role , 2017, Expert review of anti-infective therapy.

[18]  H. Kamel,et al.  First cases of Zika virus–infected US blood donors outside states with areas of active transmission , 2017, Transfusion.

[19]  B. Wallaert,et al.  An avoidable cause of thymoglobulin anaphylaxis , 2017, Allergy, Asthma & Clinical Immunology.

[20]  John-Arne Røttingen,et al.  Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) , 2017, The Lancet.

[21]  Baoshan Zhang,et al.  Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination , 2016, Nature Medicine.

[22]  M. Beltramello,et al.  Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection , 2016, Science.

[23]  Duncan R. Smith,et al.  Zika virus: history of a newly emerging arbovirus. , 2016, The Lancet. Infectious diseases.

[24]  J. Wrammert,et al.  Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus , 2016, Proceedings of the National Academy of Sciences.

[25]  Marko Kolenc,et al.  Zika Virus Associated with Microcephaly. , 2016, The New England journal of medicine.

[26]  M. Nahm,et al.  Pneumococcal Capsules and Their Types: Past, Present, and Future , 2015, Clinical Microbiology Reviews.

[27]  E. Komech,et al.  tcR: an R package for T cell receptor repertoire advanced data analysis , 2015, BMC Bioinformatics.

[28]  É. Oksenhendler,et al.  Clinical picture and treatment of 2212 patients with common variable immunodeficiency. , 2014, The Journal of allergy and clinical immunology.

[29]  O. Majdic,et al.  A Comprehensive and Quantitative Analysis of the Major Specificities in Rabbit Antithymocyte Globulin Preparations , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  Stephen R. Quake,et al.  Genetic measurement of memory B-cell recall using antibody repertoire sequencing , 2013, Proceedings of the National Academy of Sciences.

[31]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[32]  O. Majdic,et al.  Assessment of Batch to Batch Variation in Polyclonal Antithymocyte Globulin Preparations , 2012, Transplantation.

[33]  J. Dodt,et al.  Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products , 2012, Vox sanguinis.

[34]  Henrik Næsted,et al.  Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use , 2011, Biotechnology and bioengineering.

[35]  K. Jansen,et al.  Multilaboratory Comparison of Streptococcus pneumoniae Opsonophagocytic Killing Assays and Their Level of Agreement for the Determination of Functional Antibody Activity in Human Reference Sera , 2010, Clinical and Vaccine Immunology.

[36]  J. Orange,et al.  Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. , 2010, Clinical immunology.

[37]  Robert C. Edgar,et al.  Search and clustering orders of magnitude faster than BLAST , 2010, Bioinform..

[38]  Mariana Henriques,et al.  Guidelines to cell engineering for monoclonal antibody production. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[39]  Hideo Goto,et al.  In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses , 2009, Nature.

[40]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[41]  F. Hsieh,et al.  Efficacy of Hepatitis B Immune Globulin for Prevention of Perinatal Transmission of the Hepatitis B Virus Carrier State: Final Report of a Randomized Double‐Blind, Placebo‐Controlled Trial , 2007, Hepatology.

[42]  D. Burton,et al.  Fc receptor but not complement binding is important in antibody protection against HIV , 2007, Nature.

[43]  D. Brennan,et al.  Rabbit antithymocyte globulin versus basiliximab in renal transplantation. , 2006, The New England journal of medicine.

[44]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[45]  H. Simon,et al.  IVIG – mechanisms of action , 2003, Allergy.

[46]  I. Jónsdóttir,et al.  Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides , 2003, Clinical Diagnostic Laboratory Immunology.

[47]  P. Ubel,et al.  Responding to the Immunoglobulin Shortage: A Case Study , 2002, Journal of health politics, policy and law.

[48]  T. Shibui,et al.  Construction of engineered CHO strains for high-level production of recombinant proteins , 2002, Applied Microbiology and Biotechnology.

[49]  R. Ober,et al.  Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. , 2001, International immunology.

[50]  K. Lamborn,et al.  Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. , 1998, Transplantation.

[51]  S. Frøland,et al.  Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. , 1994, The New England journal of medicine.

[52]  B. Camisa,et al.  Modeling Human Graft-Versus-Host Disease in Immunocompromised Mice. , 2016, Methods in molecular biology.

[53]  J. Lantto,et al.  Human antibody repertoires. , 2009, Methods in molecular biology.

[54]  B. Mazer,et al.  Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations. , 2008, The Journal of allergy and clinical immunology.

[55]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[56]  I. Jónsdóttir,et al.  An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. , 2000, Journal of clinical microbiology.